Home/BioGenCell/Eyal Peleg, CPA, MBA
EP

Eyal Peleg, CPA, MBA

Founder, CFO

BioGenCell

BioGenCell Pipeline

DrugIndicationPhase
BGC101Chronic Limb‑Threatening Ischemia (CLTI)Phase 2
BGC10XBroad Microvascular Unmet NeedsPreclinical